Results 181 to 190 of about 4,055,008 (348)

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Tumor Cell Membrane Biomimetic Mesoporous SiliconMaterials in Combination with PD-L1 Knockout Achieved through theCRISPR/Cas9 System for Targeted and Immunotherapeutic Purposes

open access: green
Jinjin Zhao (3777973)   +8 more
openalex   +1 more source

Measuring the Spatial Arrangement of Nmj-Nachr ion Channel Proteins in the Cell Membrane [PDF]

open access: bronze, 2011
Hannah A. DeBerg   +4 more
openalex   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Biomimetic Cell Membrane-Coated Scaffolds for Enhanced Tissue Regeneration. [PDF]

open access: yesAdv Mater
Alvarez-Lorenzo C   +5 more
europepmc   +1 more source

Catalytic methanol reforming process intensification for integration with proton-exchange membrane fuel cells (PEMFC) - Review

open access: gold
Emilija Todorovski   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy